Adult T-cell leukemia/lymphoma (ATLL)
What is Adult T-cell leukemia/lymphoma (ATLL)?
Adult T-cell leukemia/lymphoma is a rare type of blood cancer. It affects your T-cells, which are white blood cells that help fight infection. This cancer is caused by a virus called HTLV-I, or human T-cell lymphotropic virus type 1.
ATLL develops slowly in most people who carry the HTLV-I virus. Most people with HTLV-I never develop cancer. Only about 2 to 5 out of 100 people with the virus will get ATLL during their lifetime. The cancer typically appears after decades of infection, usually in people over age 40.
There are four types of ATLL. Acute and lymphoma types grow quickly and need immediate treatment. Chronic and smoldering types progress slowly and may not need treatment right away. Understanding which type you have helps your doctor plan the best approach to care.
Symptoms
- Swollen lymph nodes in your neck, armpits, or groin
- Skin rashes, lumps, or patches that may be red or purple
- Frequent infections due to weakened immunity
- Fatigue and weakness that doesn't improve with rest
- Fever without an obvious cause
- Night sweats that soak your clothes or sheets
- Unintended weight loss over weeks or months
- Abdominal pain or feeling full quickly when eating
- Bone pain or fractures from weakened bones
- Confusion or changes in thinking
Some people with chronic or smoldering ATLL have no symptoms for years. The slower-growing forms may be found during routine blood tests. Acute and lymphoma types usually cause symptoms that appear quickly and worsen over weeks.
Concerned about Adult T-cell leukemia/lymphoma (ATLL)? Check your levels.
Screen for 1,200+ health conditions
Causes and risk factors
ATLL is caused by infection with the HTLV-I virus. This virus spreads through blood, from mother to baby during breastfeeding, and through sexual contact. You cannot get HTLV-I from casual contact like hugging or sharing food. The virus is most common in southwestern Japan, the Caribbean, parts of Africa, and South America. In the United States, it affects fewer than 20 out of every 100,000 people.
Having HTLV-I doesn't mean you will develop cancer. The virus must be present for decades before ATLL can develop. Risk factors include being over age 40, living in or coming from areas where HTLV-I is common, and having a mother who was infected. Men develop ATLL slightly more often than women. There are no known lifestyle factors that cause ATLL, but the cancer only occurs in people with HTLV-I infection.
How it's diagnosed
Doctors diagnose ATLL through blood tests and other specialized exams. A complete blood count shows abnormal T-cells in your bloodstream. Testing for HTLV I/II antibodies confirms infection with the virus that causes ATLL. Your doctor may also order a biopsy of lymph nodes or skin lesions to examine cancer cells under a microscope.
Additional tests help determine which type of ATLL you have. These include calcium levels, liver and kidney function tests, and imaging scans of your chest and abdomen. Specialized testing may be needed beyond standard blood panels. Talk to a doctor about which tests are right for your situation and symptoms.
Treatment options
- Watchful waiting for smoldering or chronic types with no symptoms
- Chemotherapy with multiple drugs to kill cancer cells
- Antiviral medications combined with immune system drugs
- Stem cell transplant for eligible patients with aggressive types
- Radiation therapy for specific areas affected by cancer
- Medications to manage high calcium levels in the blood
- Antibiotics or antifungals to prevent infections
- Supportive care to manage symptoms and side effects
- Clinical trials testing new treatment approaches
Frequently asked questions
ATLL is unique because it's caused by a virus, specifically HTLV-I. Most other leukemias develop from genetic changes that happen over time. ATLL only occurs in people infected with this virus, while other leukemias can affect anyone. The cancer cells in ATLL are mature T-cells, whereas other leukemias may involve different types of blood cells.
There is no proven way to prevent ATLL if you already have HTLV-I infection. Regular monitoring with your doctor can help catch changes early. Preventing HTLV-I infection in the first place is the best prevention, through safe practices and avoiding breastfeeding if you're infected. Most people with HTLV-I never develop ATLL, so having the virus doesn't guarantee you'll get cancer.
Survival depends on which type of ATLL you have. Acute and lymphoma types are aggressive, with median survival of 6 to 10 months without treatment. Chronic and smoldering types progress slowly, and people may live for years. Newer treatments and stem cell transplants have improved outcomes for some patients.
ATLL itself is not contagious. The virus that causes it, HTLV-I, can spread through blood, sexual contact, and breastfeeding. However, you cannot catch ATLL or HTLV-I through casual contact. If you have ATLL, you should take precautions to avoid spreading the virus to others through the routes mentioned.
Testing is recommended if you were born in or have lived in areas where HTLV-I is common. You should also get tested if your mother had the virus, or if you have symptoms of ATLL. Testing helps identify the virus early and allows for monitoring. Talk to a doctor about whether testing makes sense for your situation.
Early signs include swollen lymph nodes that don't go away, persistent skin rashes or lesions, and unexplained fatigue. Some people notice frequent infections or fevers without a clear cause. Many people with smoldering or chronic ATLL have no early symptoms. Regular blood tests can detect abnormal cells before symptoms appear.
Lifestyle changes cannot cure ATLL, but they support your overall health during treatment. Eating nutritious foods helps maintain strength and energy. Getting enough rest and gentle exercise when possible may improve your quality of life. Avoiding infections through good hygiene and staying away from sick people is important because ATLL weakens your immune system.
Treatment depends on your ATLL type. Aggressive forms usually require chemotherapy given through an IV over several months. You may need to stay in the hospital during initial treatment. Some patients receive antiviral drugs combined with immune system medications. Your care team will monitor your blood counts and manage side effects throughout treatment.
If you have HTLV-I without ATLL, your doctor will recommend regular check-ups. Most experts suggest physical exams and blood tests at least once a year. More frequent monitoring may be needed if you develop any symptoms or abnormal test results. Early detection of ATLL can lead to better outcomes.
Yes, researchers are studying several new approaches. Mogamulizumab is a newer targeted therapy that attacks cancer cells. Combination therapies using antiviral drugs with immune treatments show promise. Clinical trials are testing new chemotherapy combinations and immune-based treatments. Ask your doctor about clinical trials if standard treatments aren't working.